+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cell Line Development Market 2024-2028

  • PDF Icon

    Report

  • 163 Pages
  • March 2024
  • Region: Global
  • TechNavio
  • ID: 5454752
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cell line development market is forecasted to grow by USD 7.41 bn during 2023-2028, accelerating at a CAGR of 14.63% during the forecast period. The report on the cell line development market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased demand for monoclonal antibodies, patent expiration of drugs, and rise in vaccine production.

The cell line development market is segmented as below:

By Product

  • Media and reagents
  • Equipment

By Source

  • Mammalian
  • Non mammalian

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the adoption of laboratory automation as one of the prime reasons driving the cell line development market growth during the next few years. Also, emergence of data integration and artificial intelligence (AI) and advancements in genetic engineering techniques will lead to sizable demand in the market.

The report on the cell line development market covers the following areas:

  • Cell line development market sizing
  • Cell line development market forecast
  • Cell line development market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cell line development market vendors that include ATCC, Boehringer Ingelheim International GmbH, Danaher Corp., DNA TwoPointO Inc., JSR Corp., Lonza Group Ltd., MabPlex International Ltd., Premas Biotech, Promega Corp., Sartorius AG, Thermo Fisher Scientific Inc., WuXi Biologics Cayman Inc., General Electric Co., and Corning Inc.. Also, the cell line development market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Source
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Cell Line Development Market 2024-2028 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global cell line development market 2024-2028 2018 - 2022 ($ billion)
4.2 Product Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
4.3 Source Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Source Segment 2018 - 2022 ($ billion)
4.4 Region Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Region Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Product
6.1 Market segments
Exhibit 30: Chart on Product - Market share 2023-2028 (%)
Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Media and reagents - Market size and forecast 2023-2028
Exhibit 34: Chart on Media and reagents - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Media and reagents - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Media and reagents - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Media and reagents - Year-over-year growth 2023-2028 (%)
6.4 Equipment - Market size and forecast 2023-2028
Exhibit 38: Chart on Equipment - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Equipment - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Equipment - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Equipment - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Product
Exhibit 42: Market opportunity by Product ($ billion)
Exhibit 43: Data Table on Market opportunity by Product ($ billion)
7 Market Segmentation by Source
7.1 Market segments
Exhibit 44: Chart on Source - Market share 2023-2028 (%)
Exhibit 45: Data Table on Source - Market share 2023-2028 (%)
7.2 Comparison by Source
Exhibit 46: Chart on Comparison by Source
Exhibit 47: Data Table on Comparison by Source
7.3 Mammalian - Market size and forecast 2023-2028
Exhibit 48: Chart on Mammalian - Market size and forecast 2023-2028 ($ billion)
Exhibit 49: Data Table on Mammalian - Market size and forecast 2023-2028 ($ billion)
Exhibit 50: Chart on Mammalian - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on Mammalian - Year-over-year growth 2023-2028 (%)
7.4 Non mammalian - Market size and forecast 2023-2028
Exhibit 52: Chart on Non mammalian - Market size and forecast 2023-2028 ($ billion)
Exhibit 53: Data Table on Non mammalian - Market size and forecast 2023-2028 ($ billion)
Exhibit 54: Chart on Non mammalian - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Non mammalian - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Source
Exhibit 56: Market opportunity by Source ($ billion)
Exhibit 57: Data Table on Market opportunity by Source ($ billion)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 61: Chart on Geographic comparison
Exhibit 62: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 83: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
Exhibit 87: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
Exhibit 91: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Exhibit 95: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 99: Market opportunity By Geographical Landscape ($ billion)
Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 101: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 103: Overview on factors of disruption
11.4 Industry risks
Exhibit 104: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 105: Vendors covered
12.2 Market positioning of vendors
Exhibit 106: Matrix on vendor position and classification
12.3 ATCC
Exhibit 107: ATCC - Overview
Exhibit 108: ATCC - Product/Service
Exhibit 109: ATCC - Key offerings
12.4 Boehringer Ingelheim International GmbH
Exhibit 110: Boehringer Ingelheim International GmbH - Overview
Exhibit 111: Boehringer Ingelheim International GmbH - Business segments
Exhibit 112: Boehringer Ingelheim International GmbH - Key news
Exhibit 113: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 114: Boehringer Ingelheim International GmbH - Segment focus
12.5 Corning Inc.
Exhibit 115: Corning Inc. - Overview
Exhibit 116: Corning Inc. - Business segments
Exhibit 117: Corning Inc. - Key news
Exhibit 118: Corning Inc. - Key offerings
Exhibit 119: Corning Inc. - Segment focus
12.6 Danaher Corp.
Exhibit 120: Danaher Corp. - Overview
Exhibit 121: Danaher Corp. - Business segments
Exhibit 122: Danaher Corp. - Key news
Exhibit 123: Danaher Corp. - Key offerings
Exhibit 124: Danaher Corp. - Segment focus
12.7 DNA TwoPointO Inc.
Exhibit 125: DNA TwoPointO Inc. - Overview
Exhibit 126: DNA TwoPointO Inc. - Product/Service
Exhibit 127: DNA TwoPointO Inc. - Key offerings
12.8 General Electric Co.
Exhibit 128: General Electric Co. - Overview
Exhibit 129: General Electric Co. - Business segments
Exhibit 130: General Electric Co. - Key offerings
Exhibit 131: General Electric Co. - Segment focus
12.9 JSR Corp.
Exhibit 132: JSR Corp. - Overview
Exhibit 133: JSR Corp. - Business segments
Exhibit 134: JSR Corp. - Key news
Exhibit 135: JSR Corp. - Key offerings
Exhibit 136: JSR Corp. - Segment focus
12.10 Lonza Group Ltd.
Exhibit 137: Lonza Group Ltd. - Overview
Exhibit 138: Lonza Group Ltd. - Business segments
Exhibit 139: Lonza Group Ltd. - Key news
Exhibit 140: Lonza Group Ltd. - Key offerings
Exhibit 141: Lonza Group Ltd. - Segment focus
12.11 MabPlex International Ltd.
Exhibit 142: MabPlex International Ltd. - Overview
Exhibit 143: MabPlex International Ltd. - Product/Service
Exhibit 144: MabPlex International Ltd. - Key offerings
12.12 Premas Biotech
Exhibit 145: Premas Biotech - Overview
Exhibit 146: Premas Biotech - Product/Service
Exhibit 147: Premas Biotech - Key offerings
12.13 Promega Corp.
Exhibit 148: Promega Corp. - Overview
Exhibit 149: Promega Corp. - Product/Service
Exhibit 150: Promega Corp. - Key offerings
12.14 Sartorius AG
Exhibit 151: Sartorius AG - Overview
Exhibit 152: Sartorius AG - Business segments
Exhibit 153: Sartorius AG - Key news
Exhibit 154: Sartorius AG - Key offerings
Exhibit 155: Sartorius AG - Segment focus
12.15 Thermo Fisher Scientific Inc.
Exhibit 156: Thermo Fisher Scientific Inc. - Overview
Exhibit 157: Thermo Fisher Scientific Inc. - Business segments
Exhibit 158: Thermo Fisher Scientific Inc. - Key news
Exhibit 159: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 160: Thermo Fisher Scientific Inc. - Segment focus
12.16 WuXi Biologics Cayman Inc.
Exhibit 161: WuXi Biologics Cayman Inc. - Overview
Exhibit 162: WuXi Biologics Cayman Inc. - Product/Service
Exhibit 163: WuXi Biologics Cayman Inc. - Key news
Exhibit 164: WuXi Biologics Cayman Inc. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 165: Inclusions checklist
Exhibit 166: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 167: Currency conversion rates for US$
13.4 Research methodology
Exhibit 168: Research methodology
Exhibit 169: Validation techniques employed for market sizing
Exhibit 170: Information sources
13.5 List of abbreviations
Exhibit 171: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Product
Exhibits 6: Executive Summary - Chart on Market Segmentation by Source
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Historic Market Size - Data Table on global cell line development market 2024-2028 2018 - 2022 ($ billion)
Exhibits 19: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
Exhibits 20: Historic Market Size - Source Segment 2018 - 2022 ($ billion)
Exhibits 21: Historic Market Size - Region Segment 2018 - 2022 ($ billion)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Product - Market share 2023-2028 (%)
Exhibits 31: Data Table on Product - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Product
Exhibits 33: Data Table on Comparison by Product
Exhibits 34: Chart on Media and reagents - Market size and forecast 2023-2028 ($ billion)
Exhibits 35: Data Table on Media and reagents - Market size and forecast 2023-2028 ($ billion)
Exhibits 36: Chart on Media and reagents - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Media and reagents - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Equipment - Market size and forecast 2023-2028 ($ billion)
Exhibits 39: Data Table on Equipment - Market size and forecast 2023-2028 ($ billion)
Exhibits 40: Chart on Equipment - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Equipment - Year-over-year growth 2023-2028 (%)
Exhibits 42: Market opportunity by Product ($ billion)
Exhibits 43: Data Table on Market opportunity by Product ($ billion)
Exhibits 44: Chart on Source - Market share 2023-2028 (%)
Exhibits 45: Data Table on Source - Market share 2023-2028 (%)
Exhibits 46: Chart on Comparison by Source
Exhibits 47: Data Table on Comparison by Source
Exhibits 48: Chart on Mammalian - Market size and forecast 2023-2028 ($ billion)
Exhibits 49: Data Table on Mammalian - Market size and forecast 2023-2028 ($ billion)
Exhibits 50: Chart on Mammalian - Year-over-year growth 2023-2028 (%)
Exhibits 51: Data Table on Mammalian - Year-over-year growth 2023-2028 (%)
Exhibits 52: Chart on Non mammalian - Market size and forecast 2023-2028 ($ billion)
Exhibits 53: Data Table on Non mammalian - Market size and forecast 2023-2028 ($ billion)
Exhibits 54: Chart on Non mammalian - Year-over-year growth 2023-2028 (%)
Exhibits 55: Data Table on Non mammalian - Year-over-year growth 2023-2028 (%)
Exhibits 56: Market opportunity by Source ($ billion)
Exhibits 57: Data Table on Market opportunity by Source ($ billion)
Exhibits 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 61: Chart on Geographic comparison
Exhibits 62: Data Table on Geographic comparison
Exhibits 63: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits 64: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits 65: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 67: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits 68: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 71: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits 72: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 79: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 80: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 81: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 82: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 83: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits 84: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits 85: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 86: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 87: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits 88: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits 89: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 90: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 91: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits 92: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits 93: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 94: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 95: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits 96: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits 97: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 98: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 99: Market opportunity By Geographical Landscape ($ billion)
Exhibits 100: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits 101: Impact of drivers and challenges in 2023 and 2028
Exhibits 102: Overview on Criticality of inputs and Factors of differentiation
Exhibits 103: Overview on factors of disruption
Exhibits 104: Impact of key risks on business
Exhibits 105: Vendors covered
Exhibits 106: Matrix on vendor position and classification
Exhibits 107: ATCC - Overview
Exhibits 108: ATCC - Product/Service
Exhibits 109: ATCC - Key offerings
Exhibits 110: Boehringer Ingelheim International GmbH - Overview
Exhibits 111: Boehringer Ingelheim International GmbH - Business segments
Exhibits 112: Boehringer Ingelheim International GmbH - Key news
Exhibits 113: Boehringer Ingelheim International GmbH - Key offerings
Exhibits 114: Boehringer Ingelheim International GmbH - Segment focus
Exhibits 115: Corning Inc. - Overview
Exhibits 116: Corning Inc. - Business segments
Exhibits 117: Corning Inc. - Key news
Exhibits 118: Corning Inc. - Key offerings
Exhibits 119: Corning Inc. - Segment focus
Exhibits 120: Danaher Corp. - Overview
Exhibits 121: Danaher Corp. - Business segments
Exhibits 122: Danaher Corp. - Key news
Exhibits 123: Danaher Corp. - Key offerings
Exhibits 124: Danaher Corp. - Segment focus
Exhibits 125: DNA TwoPointO Inc. - Overview
Exhibits 126: DNA TwoPointO Inc. - Product/Service
Exhibits 127: DNA TwoPointO Inc. - Key offerings
Exhibits 128: General Electric Co. - Overview
Exhibits 129: General Electric Co. - Business segments
Exhibits 130: General Electric Co. - Key offerings
Exhibits 131: General Electric Co. - Segment focus
Exhibits 132: JSR Corp. - Overview
Exhibits 133: JSR Corp. - Business segments
Exhibits 134: JSR Corp. - Key news
Exhibits 135: JSR Corp. - Key offerings
Exhibits 136: JSR Corp. - Segment focus
Exhibits 137: Lonza Group Ltd. - Overview
Exhibits 138: Lonza Group Ltd. - Business segments
Exhibits 139: Lonza Group Ltd. - Key news
Exhibits 140: Lonza Group Ltd. - Key offerings
Exhibits 141: Lonza Group Ltd. - Segment focus
Exhibits 142: MabPlex International Ltd. - Overview
Exhibits 143: MabPlex International Ltd. - Product/Service
Exhibits 144: MabPlex International Ltd. - Key offerings
Exhibits 145: Premas Biotech - Overview
Exhibits 146: Premas Biotech - Product/Service
Exhibits 147: Premas Biotech - Key offerings
Exhibits 148: Promega Corp. - Overview
Exhibits 149: Promega Corp. - Product/Service
Exhibits 150: Promega Corp. - Key offerings
Exhibits 151: Sartorius AG - Overview
Exhibits 152: Sartorius AG - Business segments
Exhibits 153: Sartorius AG - Key news
Exhibits 154: Sartorius AG - Key offerings
Exhibits 155: Sartorius AG - Segment focus
Exhibits 156: Thermo Fisher Scientific Inc. - Overview
Exhibits 157: Thermo Fisher Scientific Inc. - Business segments
Exhibits 158: Thermo Fisher Scientific Inc. - Key news
Exhibits 159: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 160: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 161: WuXi Biologics Cayman Inc. - Overview
Exhibits 162: WuXi Biologics Cayman Inc. - Product/Service
Exhibits 163: WuXi Biologics Cayman Inc. - Key news
Exhibits 164: WuXi Biologics Cayman Inc. - Key offerings
Exhibits 165: Inclusions checklist
Exhibits 166: Exclusions checklist
Exhibits 167: Currency conversion rates for US$
Exhibits 168: Research methodology
Exhibits 169: Validation techniques employed for market sizing
Exhibits 170: Information sources
Exhibits 171: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global cell line development market: ATCC, Boehringer Ingelheim International GmbH, Danaher Corp., DNA TwoPointO Inc., JSR Corp., Lonza Group Ltd., MabPlex International Ltd., Premas Biotech, Promega Corp., Sartorius AG, Thermo Fisher Scientific Inc., WuXi Biologics Cayman Inc., General Electric Co., and Corning Inc..

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is adoption of laboratory automation.'

According to the report, one of the major drivers for this market is the increased demand for monoclonal antibodies.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • ATCC
  • Boehringer Ingelheim International GmbH
  • Danaher Corp.
  • DNA TwoPointO Inc.
  • JSR Corp.
  • Lonza Group Ltd.
  • MabPlex International Ltd.
  • Premas Biotech
  • Promega Corp.
  • Sartorius AG
  • Thermo Fisher Scientific Inc.
  • WuXi Biologics Cayman Inc.
  • General Electric Co.
  • Corning Inc.